Latest News about AZN
Recent news which mentions AZN
The Implications Behind Genetron Health's Latest Earnings Report
December 03, 2021
From Benzinga
AstraZeneca Blocks SOBI's $8B Buyout, Advent Withdraws The Bid - Report
December 03, 2021
From Benzinga
From Benzinga
Is High Pressure Good for Drug Development?
December 02, 2021
From Benzinga
Breakthrough Cancer Therapy? This Biotech Shares Preclinical Data and Ambitious Plans
December 02, 2021
From Benzinga
From Motley Fool
Have the Markets Overreacted to Omicron?
November 30, 2021
From InvestorPlace
7 Drug Stocks to Buy Now While They’re Still on Sale
November 30, 2021
From InvestorPlace
Why Shares of Genetron Holdings Are Up More than 9.3% on Tuesday
November 30, 2021
From Motley Fool
The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout
November 30, 2021
From Benzinga
From Benzinga
Novavax Is a Buy Based on Its Outlook, But Not for the Long Haul
November 29, 2021
From InvestorPlace
From Benzinga
These Biotech Companies Are Attempting to Use Improved Antibody Technology in the Fight To Eradicate COVID-19
November 29, 2021
From Benzinga
Got $5,000? These 2 Stocks Could Be Bargain Buys in 2022
November 27, 2021
From Motley Fool
WHO urges world leaders not to have knee-jerk reaction to new coronavirus variant from South Africa as UK and EU impose travel bans
November 26, 2021
From MarketWatch
On an ugly day for markets, here’s the S&P 500 level investors need to watch closely, says this trader
November 26, 2021
From MarketWatch
From Benzinga
AstraZeneca Decides It's OK to Make Money From the Pandemic
November 23, 2021
From Motley Fool
EU Says Decision On J&J COVID-19 Booster Shot Expected 'Within Weeks'
November 22, 2021
From Benzinga
1 Cancer Stock on Buyout Watch in 2022
November 21, 2021
From Motley Fool
2 Dividend Stocks to Buy Right Now
November 19, 2021
From Motley Fool
Face masks and distancing are most effective measures in reducing COVID-19 spread, study finds, as experts clamor for U.S. to expand booster program
November 18, 2021
From MarketWatch
The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings
November 18, 2021
From Benzinga
AstraZeneca's COVID-19 Antibody Shows 83% Protection Over Six Months
November 18, 2021
From Benzinga
AstraZeneca: Studies show antibody reduces COVID risk
November 18, 2021
Tickers
AZN
From MarketWatch
Why Novavax Beat the Market on Monday
November 15, 2021
From Motley Fool
From Benzinga
PhaseBio's Shares Slide As Antiplatelet Candidate Shows Higher Rates Of Side Effect
November 15, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.